Skip to content

Growth Stocks

Undervalued Growth Stocks To Buy Now? 5 For Your Watchlist

After a tumultuous first half for the global stock market, you would expect investors to put their money into safer investments. After all, a looming recession, runaway inflation, and an energy crisis are all suggesting investors to dump stocks and look for safer investments such as bonds. But that doesn’t mean that it is all gloom and doom. After all,… 

7 Best Growth ETFs To Buy Now

Declines in growth stocks amid inflation and rising interest rates provide a buying opportunity. Growth stocks are those that are expected by the market to increase their revenues and earnings faster on average than others in the same industry. These high-flying stocks tend to hail from the technology and communications sectors, and often exhibit elevated valuations in the form of high… 

9 Growth Stocks That Also Pay Dividends

Analysts recommend these dividend-paying growth stocks. Most high-growth companies reinvest every spare dime into expanding their businesses. However, one of the first things companies do when growth finally starts to level off is to begin returning excess cash to shareholders via dividend payments. Fortunately, there are a handful of companies that generate impressive growth numbers and also pay dividends. Many… 

3 Strategies For Picking The Best Growth Stocks

Investing in growth stocks is a well-traveled path to unlocking life-changing wealth from the stock market. That’s because most of the biggest winners of our lifetime come from the growth camp. Especially those growth companies with… Continue reading here. This article originally appeared at StockNews.

Growth, Income And Impact Make These 3 Pharma Stocks Among The Best Picks Right Now

“The best big pharma stocks offer growth potential thanks to strong pipelines, steady income with dependable dividends, and the opportunity to invest in a business that can make a huge positive impact in the lives of millions of people,” advises the author of today’s article, who proceeds to highlight three such pharma stocks that may be among the best picks… 

These 3 Stocks Meet The Profile For “Monster Growth”

When it comes to creating a useful profile for monster growth stocks, the author of today’s article lays out the following criteria: “gangbusters gains, Buy ratings from the Wall Street analyst corps, and considerable upside for the coming year.” With that, he proceeds to highlight three stocks that meet the profile for monster growth, including one that “puts a different… 

4 Stocks To Play This “Hot Technology Silo”

Of the four stocks highlighted in today’s article, the author declares them “outstanding ideas for aggressive growth investors looking to add this hot technology silo.” The silo in question? Cybersecurity and analytics, which, in a new research report, Goldman Sachs is very positive on. For four top new trends in cybersecurity and analytics that Goldman noted in its report, as… 

Top Tech Trading Under $10

Based on the premise that tech is poised to continue to drive the market for years to come, today’s article highlights three cheap (trading under $10 a share) stocks from the broader technology space to consider due to their growth prospects regardless of renewed market volatility. For more on these three tech stocks, CLICK HERE.

Looking Beyond Dividend Stocks For Solid Retirement Investments

“Although dividend stocks are a mainstay of a retirement portfolio, they are not the only stocks you should have,” advises the author of today’s article, who proceeds to highlight three stocks offering income and growth to consider for retirement. For these three stocks, as well as the author’s advice regarding the right amount of portfolio diversification in retirement and his… 

The Next Market Reality – And 3 Beaten-Down Stocks That Could Thrive In It

In regards to the likes of Amazon, the author of today’s article suggests that “the off-the-charts outperformance by its stock – and others like it – may be coming to an end” as a new market reality – wherein the tide shifts in favor of value stocks and away from growth stocks (which have outperformed for quite some time) –…